Cargando…
The Persister Character of Clinical Isolates of Staphylococcus aureus Contributes to Faster Evolution to Resistance and Higher Survival in THP-1 Monocytes: A Study With Moxifloxacin
Staphylococcus aureus may cause relapsing infections. We previously showed that S. aureus SH1000 surviving intracellularly to bactericidal antibiotics are persisters. Here, we used 54 non-duplicate clinical isolates to assess links between persistence, resistance evolution, and intracellular surviva...
Autores principales: | Nguyen, Tiep K., Peyrusson, Frédéric, Dodémont, Magali, Pham, Nhung H., Nguyen, Hoang A., Tulkens, Paul M., Van Bambeke, Françoise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719683/ https://www.ncbi.nlm.nih.gov/pubmed/33329458 http://dx.doi.org/10.3389/fmicb.2020.587364 |
Ejemplares similares
-
Activity of Moxifloxacin Against Biofilms Formed by Clinical Isolates of Staphylococcus aureus Differing by Their Resistant or Persister Character to Fluoroquinolones
por: Nguyen, Tiep K., et al.
Publicado: (2021) -
Host Cell Oxidative Stress Induces Dormant Staphylococcus aureus Persisters
por: Peyrusson, Frédéric, et al.
Publicado: (2022) -
Cellular Pharmacokinetics and Intracellular Activity of Gepotidacin against Staphylococcus aureus Isolates with Different Resistance Phenotypes in Models of Cultured Phagocytic Cells
por: Peyrusson, Frédéric, et al.
Publicado: (2018) -
Intracellular Staphylococcus aureus persisters upon antibiotic exposure
por: Peyrusson, Frédéric, et al.
Publicado: (2020) -
Moxifloxacin Safety: An Analysis of 14 Years of Clinical Data
por: Tulkens, Paul M., et al.
Publicado: (2012)